Literature DB >> 21963785

Intragenic deletion as a novel type of mutation in Wolman disease.

Teresa M Lee1, Mariko Welsh, Sonia Benhamed, Wendy K Chung.   

Abstract

Two clinically distinct disorders, Wolman disease (WD) and cholesteryl ester storage disease (CESD), are allelic autosomal recessive disorders caused by different mutations in lysosomal acid lipase (LIPA) which encodes for an essential enzyme involved in the hydrolysis of intracellular cholesteryl esters and triglycerides. We describe a case of lysosomal acid lipase deficiency in an infant with WD and report on a novel mutation type, intragenic deletion.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21963785      PMCID: PMC3781170          DOI: 10.1016/j.ymgme.2011.09.006

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  17 in total

1.  Lysosomal acid lipase mutations that determine phenotype in Wolman and cholesterol ester storage disease.

Authors:  R A Anderson; G M Bryson; J S Parks
Journal:  Mol Genet Metab       Date:  1999-11       Impact factor: 4.797

2.  A 5' splice-region mutation and a dinucleotide deletion in the lysosomal acid lipase gene in two patients with cholesteryl ester storage disease.

Authors:  D Ameis; G Brockmann; R Knoblich; M Merkel; R E Ostlund; J W Yang; P M Coates; J A Cortner; S V Feinman; H Greten
Journal:  J Lipid Res       Date:  1995-02       Impact factor: 5.922

3.  In situ localization of the genetic locus encoding the lysosomal acid lipase/cholesteryl esterase (LIPA) deficient in Wolman disease to chromosome 10q23.2-q23.3.

Authors:  R A Anderson; N Rao; R S Byrum; C B Rothschild; D W Bowden; R Hayworth; M Pettenati
Journal:  Genomics       Date:  1993-01       Impact factor: 5.736

4.  A splice junction mutation causes deletion of a 72-base exon from the mRNA for lysosomal acid lipase in a patient with cholesteryl ester storage disease.

Authors:  H Klima; K Ullrich; C Aslanidis; P Fehringer; K J Lackner; G Schmitz
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

5.  Genomic organization of the human lysosomal acid lipase gene (LIPA).

Authors:  C Aslanidis; H Klima; K J Lackner; G Schmitz
Journal:  Genomics       Date:  1994-03-15       Impact factor: 5.736

6.  Assignment of LIPA, associated with human acid lipase deficiency, to human chromosome 10 and comparative assignment to mouse chromosome 19.

Authors:  G Koch; P A Lalley; M McAvoy; T B Shows
Journal:  Somatic Cell Genet       Date:  1981-05

7.  A histidine to tyrosine replacement in lysosomal acid lipase causes cholesteryl ester storage disease.

Authors:  F Pagani; L Zagato; G Merati; G Paone; B Gridelli; J A Maier
Journal:  Hum Mol Genet       Date:  1994-09       Impact factor: 6.150

8.  Molecular defects underlying Wolman disease appear to be more heterogeneous than those resulting in cholesteryl ester storage disease.

Authors:  P Lohse; S Maas; A C Sewell; D Seidel
Journal:  J Lipid Res       Date:  1999-02       Impact factor: 5.922

9.  Long-term metabolic, endocrine, and neuropsychological outcome of hematopoietic cell transplantation for Wolman disease.

Authors:  J Tolar; A Petryk; K Khan; K J Bjoraker; J Jessurun; M Dolan; T Kivisto; L Charnas; E G Shapiro; P J Orchard
Journal:  Bone Marrow Transplant       Date:  2008-09-08       Impact factor: 5.483

10.  A novel variant of lysosomal acid lipase (Leu336-->Pro) associated with acid lipase deficiency and cholesterol ester storage disease.

Authors:  U Seedorf; H Wiebusch; S Muntoni; N C Christensen; F Skovby; V Nickel; M Roskos; H Funke; L Ose; G Assmann
Journal:  Arterioscler Thromb Vasc Biol       Date:  1995-06       Impact factor: 8.311

View more
  4 in total

1.  Wolman's disease presenting with secondary hemophagocytic lymphohistiocytosis: a case report from Saudi Arabia and literature review.

Authors:  Fahad Alabbas; Ghaleb Elyamany; Talal Alanzi; Tahani Bin Ali; Fatma Albatniji; Huda Alfaraidi
Journal:  BMC Pediatr       Date:  2021-02-10       Impact factor: 2.125

2.  Sebelipase alfa enzyme replacement therapy in Wolman disease: a nationwide cohort with up to ten years of follow-up.

Authors:  Tanguy Demaret; Florence Lacaille; Camille Wicker; Jean-Baptiste Arnoux; Juliette Bouchereau; Claire Belloche; Cyril Gitiaux; David Grevent; Christine Broissand; Dalila Adjaoud; Marie-Thérèse Abi Warde; Dominique Plantaz; Soumeya Bekri; Pascale de Lonlay; Anaïs Brassier
Journal:  Orphanet J Rare Dis       Date:  2021-12-14       Impact factor: 4.123

Review 3.  Genes Potentially Associated with Familial Hypercholesterolemia.

Authors:  Svetlana Mikhailova; Dinara Ivanoshchuk; Olga Timoshchenko; Elena Shakhtshneider
Journal:  Biomolecules       Date:  2019-11-29

Review 4.  Lysosomal acid lipase deficiency in pediatric patients: a scoping review.

Authors:  Camila da Rosa Witeck; Anne Calbusch Schmitz; Júlia Meller Dias de Oliveira; André Luís Porporatti; Graziela De Luca Canto; Maria Marlene de Souza Pires
Journal:  J Pediatr (Rio J)       Date:  2021-05-06       Impact factor: 2.990

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.